Bernstein SocGen Group Reiterates Market Perform Rating on BioNTech (BNTX)
Tweet Send to a Friend
Bernstein SocGen Group analyst Jeffrey Walch reiterated a Market Perform rating and $96.00 price target on BioNTech (NASDAQ: BNTX).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
